Zhengxia Wang
Nanjing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications
Clinical characteristics and risk factors associated with severe community-acquired pneumonia infected by Chlamydia psittaci.
Journal: Microbiology spectrum
Published: September 24, 2025
IFITM1 is required for epithelial mesenchymal transition in airway remodeling of allergic asthma.
Journal: The World Allergy Organization journal
Published: May 13, 2025
MMP-12 blockade in B lymphocytes inhibits the formation of inducible BALTs and alleviates neutrophilic allergic airway inflammation.
Journal: International immunopharmacology
Published: May 02, 2025
Corrigendum to "Exosomes in malignant pleural effusion from lung cancer patients impaired the cytotoxicity of double-negative T cells" [Translational Oncology 27 (2023) 1-9/101564].
Journal: Translational oncology
Published: December 09, 2024
METTL16 controls airway inflammations in smoking-induced COPD via regulating glutamine metabolism.
Journal: Ecotoxicology and environmental safety
Published: September 04, 2024
TOM5 regulates the mitochondrial membrane potential of alveolar epithelial cells in organizing pneumonia.
Journal: Redox report : communications in free radical research
Published: May 25, 2024
A micropeptide TREMP encoded by lincR-PPP2R5C promotes Th2 cell differentiation by interacting with PYCR1 in allergic airway inflammation.
Journal: Allergology international : official journal of the Japanese Society of Allergology
Published: December 13, 2023
LincR-PPP2R5C regulates IL-1β ubiquitination in macrophages and promotes airway inflammation and emphysema in a murine model of COPD.
Journal: International immunopharmacology
Published: November 17, 2023
LincR-PPP2R5C Deficiency Alleviates Airway Remodeling by Inhibiting Epithelial-Mesenchymal Transition Through the PP2A/TGF-β1 Signaling Pathway in Chronic Experimental Allergic Asthma.
Journal: Allergy, asthma & immunology research
Published: November 01, 2023
Plasma sCD146 is a potential biomarker for acute exacerbation of chronic obstructive pulmonary disease.
Journal: Clinical and translational science
Published: October 13, 2023
CD146 deficiency aggravates chronic obstructive pulmonary disease via the increased production of S100A9 and MMP-9 in macrophages.
Journal: International immunopharmacology
Published: October 12, 2023
Last Updated: 09/26/2026